User profiles for Carolyn Williamson

Carolyn Williamson

University of Cape Town
Verified email at uct.ac.za
Cited by 21668

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

…, W Preiser, F Treurnicht, M Venter, C Williamson… - Nature, 2022 - nature.com
The SARS-CoV-2 epidemic in southern Africa has been characterized by three distinct waves.
The first was associated with a mix of SARS-CoV-2 lineages, while the second and third …

Detection of a SARS-CoV-2 variant of concern in South Africa

…, D Martin, RJ Lessells, JN Bhiman, C Williamson… - Nature, 2021 - nature.com
Continued uncontrolled transmission of SARS-CoV-2 in many parts of the world is creating
conditions for substantial evolutionary changes to the virus 1 , 2 . Here we describe a newly …

Emergence of SARS-CoV-2 omicron lineages BA. 4 and BA. 5 in South Africa

…, C Roemer, SL Kosakovsky Pond, C Williamson… - Nature medicine, 2022 - nature.com
Three lineages (BA.1, BA.2 and BA.3) of the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) Omicron variant of concern predominantly drove South Africa’s fourth …

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa

…, D Martin, RJ Lessells, JN Bhiman, C Williamson… - medrxiv, 2020 - medrxiv.org
Continued uncontrolled transmission of the severe acute respiratory syndrome-related
coronavirus 2 (SARS-CoV-2) in many parts of the world is creating the conditions for significant …

RDP2: recombination detection and analysis from sequence alignments

DP Martin, C Williamson, D Posada - Bioinformatics, 2005 - academic.oup.com
RDP2 is a Windows 95/XP program that examines nucleotide sequence alignments and
attempts to identify recombinant sequences and recombination breakpoints using 10 published …

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

…, JP Moore, AB Ward, G Georgiou, C Williamson… - Nature, 2014 - nature.com
Antibodies capable of neutralizing HIV-1 often target variable regions 1 and 2 (V1V2) of the
HIV-1 envelope, but the mechanism of their elicitation has been unclear. Here we define the …

Sixteen novel lineages of SARS-CoV-2 in South Africa

…, S Engelbrecht, G Van Zyl, W Preiser, C Williamson… - Nature medicine, 2021 - nature.com
The first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in South
Africa was identified on 5 March 2020, and by 26 March the country was in full lockdown (…

The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection

…, L Werner, K Mlisana, S Sibeko, C Williamson… - Journal of …, 2011 - Am Soc Microbiol
An understanding of how broadly neutralizing activity develops in HIV-1-infected individuals
is needed to guide vaccine design and immunization strategies. Here we used a large …

[HTML][HTML] Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition

…, LR Baden, JI Mullins, C Williamson… - … England Journal of …, 2021 - Mass Medical Soc
Background Whether a broadly neutralizing antibody (bnAb) can be used to prevent human
immunodeficiency virus type 1 (HIV-1) acquisition is unclear. Methods We enrolled at-risk …

Genital inflammation and the risk of HIV acquisition in women

…, C Baxter, KB Arnold, C Williamson… - Clinical Infectious …, 2015 - academic.oup.com
Background. Women in Africa, especially young women, have very high human immunodeficiency
virus (HIV) incidence rates that cannot be fully explained by behavioral risks. We …